• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有严重反流的自体瓣膜感染性心内膜炎:关键在于心力衰竭。

Native Valve Infective Endocarditis with Severe Regurgitation: What Matters Is Heart Failure.

作者信息

Lozano Ibañez Adrián, Pulido Paloma, López Díaz Javier, de Miguel María, Cabezón Gonzalo, Oña Andrea, Zulet Pablo, Jerónimo Adrián, Gómez Daniel, Pinilla-García Daniel, Olmos Carmen, Sáez Carmen, Pérez-Serrano Javier B, Vilacosta Isidre, Gómez-Salvador Itziar, San Román J Alberto

机构信息

Servicio de Cardiología, Instituto de Ciencias del Corazón (ICICOR), Hospital Clínico Universitario de Valladolid, 47003 Valladolid, Spain.

Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain.

出版信息

J Clin Med. 2024 Oct 18;13(20):6222. doi: 10.3390/jcm13206222.

DOI:10.3390/jcm13206222
PMID:39458178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11508464/
Abstract

Heart failure worsens the prognosis of patients with infective endocarditis (IE) and is mainly caused by severe valvular regurgitation. The aim of our investigation is to describe the clinical, epidemiological, microbiological, and echocardiographic characteristics of patients with native left-sided infective endocarditis (NLSIE) with severe valvular regurgitation; to describe the prognosis according to the therapeutic approach; and to determine the prognostic factors of in-hospital mortality. : We prospectively recruited all episodes of possible or definite NLSIE diagnosed at three tertiary hospitals between 2005 and 2022. Patients were divided into two groups: patients with severe valvular regurgitation at the time of admission or during hospitalization and patients without severe valvular regurgitation. We analyzed up to 85 variables concerning epidemiological, clinical, analytical, microbiological, and echocardiographic data. : We recovered 874 patients with NLSIE, 564 (65%) of them with severe valvular regurgitation. There were no differences in mortality among patients with and without severe regurgitation (30.2% vs. 26.5%, = 0.223). However, mortality increased when patients with severe regurgitation developed heart failure (33% vs. 11.4%, < 0.001). Independent factors related to heart failure were age (OR 1.02 [1.01-1.034], = 0.001), anemia (OR 1.2 [1.18-3.31], = 0.01), atrial fibrillation (OR 2.3 [1.08-4.89], = 0.03), -related IE (OR 0.47 [0.3-0.73], = 0.001), and mitroaortic severe regurgitation (OR 2.4 [1.15-5.02], = 0.019). : Severe valvular regurgitation is very frequent among patients with NLSIE, but it does not worsen the prognosis of patients unless complicated with heart failure.

摘要

心力衰竭会使感染性心内膜炎(IE)患者的预后恶化,且主要由严重的瓣膜反流引起。我们研究的目的是描述伴有严重瓣膜反流的原发性左侧感染性心内膜炎(NLSIE)患者的临床、流行病学、微生物学和超声心动图特征;根据治疗方法描述预后情况;并确定住院死亡率的预后因素。我们前瞻性地纳入了2005年至2022年期间在三家三级医院诊断出的所有可能或确诊的NLSIE病例。患者被分为两组:入院时或住院期间伴有严重瓣膜反流的患者和无严重瓣膜反流的患者。我们分析了多达85项有关流行病学、临床、分析、微生物学和超声心动图数据的变量。我们共纳入了874例NLSIE患者,其中564例(65%)伴有严重瓣膜反流。有严重反流和无严重反流的患者死亡率无差异(30.2%对26.5%,P = 0.223)。然而,当伴有严重反流的患者发生心力衰竭时,死亡率会升高(33%对11.4%,P < 0.001)。与心力衰竭相关的独立因素有年龄(OR 1.02 [1.01 - 1.034],P = 0.001)、贫血(OR 1.2 [1.18 - 3.31],P = 0.01)、心房颤动(OR 2.3 [1.08 - 4.89],P = 0.03)、静脉药物滥用相关的IE(OR 0.47 [0.3 - 0.73],P = 0.001)以及二尖瓣主动脉瓣严重反流(OR 2.4 [1.15 - 5.02],P = 0.019)。严重瓣膜反流在NLSIE患者中非常常见,但除非并发心力衰竭,否则不会使患者预后恶化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3507/11508464/e1c76451d71e/jcm-13-06222-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3507/11508464/8ae3227d3a14/jcm-13-06222-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3507/11508464/e1c76451d71e/jcm-13-06222-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3507/11508464/8ae3227d3a14/jcm-13-06222-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3507/11508464/e1c76451d71e/jcm-13-06222-g002.jpg

相似文献

1
Native Valve Infective Endocarditis with Severe Regurgitation: What Matters Is Heart Failure.伴有严重反流的自体瓣膜感染性心内膜炎:关键在于心力衰竭。
J Clin Med. 2024 Oct 18;13(20):6222. doi: 10.3390/jcm13206222.
2
Prognostic significance of valvular regurgitation in patients with infective endocarditis.感染性心内膜炎患者瓣膜反流的预后意义
Am J Med. 1991 Feb;90(2):193-7.
3
Epidemiological, clinical and microbiological profile of infective endocarditis in a tertiary hospital in the South-East Anatolia Region.东南安纳托利亚地区一家三级医院感染性心内膜炎的流行病学、临床和微生物学特征
Turk Kardiyol Dern Ars. 2010 Mar;38(2):107-11.
4
Value of echocardiographic findings in predicting cardiovascular complications in infective endocarditis.超声心动图检查结果在预测感染性心内膜炎心血管并发症中的价值
Angiology. 2001 Dec;52(12):801-9. doi: 10.1177/000331970105201201.
5
Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure.感染性心内膜炎合并心力衰竭患者行瓣膜手术后的死亡率。
JAMA. 2011 Nov 23;306(20):2239-47. doi: 10.1001/jama.2011.1701.
6
Infective endocarditis without biological inflammatory syndrome: Description of a particular entity.无生物炎症综合征感染性心内膜炎:一种特殊实体的描述。
Arch Cardiovasc Dis. 2019 Jun-Jul;112(6-7):381-389. doi: 10.1016/j.acvd.2019.02.005. Epub 2019 Jul 11.
7
Characteristics, management, and outcomes of patients with left-sided infective endocarditis complicated by heart failure: a substudy of the ESC-EORP EURO-ENDO (European infective endocarditis) registry.左心感染性心内膜炎合并心力衰竭患者的特征、治疗和结局:ESC-EORP EURO-ENDO(欧洲感染性心内膜炎)注册研究的一个子研究。
Eur J Heart Fail. 2022 Jul;24(7):1253-1265. doi: 10.1002/ejhf.2525. Epub 2022 May 16.
8
Long-term prognosis of left-sided native-valve Staphylococcus aureus endocarditis.左侧自体瓣膜金黄色葡萄球菌性心内膜炎的长期预后
Arch Cardiovasc Dis. 2016 Apr;109(4):260-7. doi: 10.1016/j.acvd.2015.11.012. Epub 2016 Feb 15.
9
Predictors of mortality and adverse events in patients with infective endocarditis: a retrospective real world study in a surgical centre.感染性心内膜炎患者的死亡率和不良事件的预测因素:外科中心的回顾性真实世界研究。
BMC Cardiovasc Disord. 2021 Jan 12;21(1):28. doi: 10.1186/s12872-021-01853-6.
10
Valve regurgitation in patients surviving endocarditis and the subsequent risk of heart failure.存活于心内膜炎患者的瓣膜反流及随后心力衰竭的风险。
Heart. 2020 Jul;106(13):1015-1022. doi: 10.1136/heartjnl-2019-315715. Epub 2019 Dec 10.

本文引用的文献

1
Clinical Features and Patient Outcomes in Infective Endocarditis with Surgical Indication: A Single-Centre Experience.有手术指征的感染性心内膜炎的临床特征及患者预后:单中心经验
J Cardiovasc Dev Dis. 2024 Apr 29;11(5):138. doi: 10.3390/jcdd11050138.
2
Acute Heart Valve Emergencies.急性心脏瓣膜急症。
Cardiol Clin. 2024 May;42(2):237-252. doi: 10.1016/j.ccl.2024.02.009.
3
Contemporary Clinical Profile of Left-Sided Native Valve Infective Endocarditis: Influence of the Causative Microorganism.左侧自体瓣膜感染性心内膜炎的当代临床特征:致病微生物的影响
J Clin Med. 2023 Aug 22;12(17):5441. doi: 10.3390/jcm12175441.
4
2023 ESC Guidelines for the management of endocarditis.2023年欧洲心脏病学会感染性心内膜炎管理指南。
Eur Heart J. 2023 Oct 14;44(39):3948-4042. doi: 10.1093/eurheartj/ehad193.
5
Characteristics, management, and outcomes of patients with left-sided infective endocarditis complicated by heart failure: a substudy of the ESC-EORP EURO-ENDO (European infective endocarditis) registry.左心感染性心内膜炎合并心力衰竭患者的特征、治疗和结局:ESC-EORP EURO-ENDO(欧洲感染性心内膜炎)注册研究的一个子研究。
Eur J Heart Fail. 2022 Jul;24(7):1253-1265. doi: 10.1002/ejhf.2525. Epub 2022 May 16.
6
Infective endocarditis treated in a secondary hospital: epidemiological, clinical, microbiological characteristics and prognosis, with special reference to patients transferred to a third level hospital.在二级医院治疗的感染性心内膜炎:流行病学、临床、微生物学特征和预后,特别关注转至三级医院的患者。
Rev Esp Quimioter. 2022 Feb;35(1):35-42. doi: 10.37201/req/092.2021. Epub 2021 Nov 30.
7
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
8
Mitral Regurgitation in Patients With Coexisting Chronic Aortic Regurgitation: An Evidence-Based Narrative Review.合并慢性主动脉瓣反流的二尖瓣反流患者:基于证据的叙述性综述。
J Cardiothorac Vasc Anesth. 2021 Nov;35(11):3404-3415. doi: 10.1053/j.jvca.2021.01.003. Epub 2021 Jan 8.
9
Characteristics and Prognosis of Patients With Left-Sided Native Bivalvular Infective Endocarditis.左侧天然双瓣生物瓣膜感染性心内膜炎患者的特征与预后
Can J Cardiol. 2021 Feb;37(2):292-299. doi: 10.1016/j.cjca.2020.03.046. Epub 2020 Apr 9.
10
Risk Factors for In-Hospital Mortality in Infective Endocarditis.感染性心内膜炎患者住院期间死亡的危险因素。
Arq Bras Cardiol. 2020 Jan;114(1):1-8. doi: 10.36660/abc.20180194.